CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 3,000 shares (option exercise)
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 3,937 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale EVP, GENERAL COUNSEL sold 25,000 shares at $31.70 ($792,548)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 25,000 shares at $31.70 ($792,540)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Director sold 7,529 shares at $32.00 ($240,928)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, GENERAL COUNSEL sold 25,000 shares at $30.12 ($752,935)
- 4 Planned sale Director sold 115,000 shares at an average $30.57 ($3,515,468)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 25,000 shares at $30.13 ($753,153)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 144 Insider Sale of Securities
Page 2 of 49 · 965 filings